Number of the records: 1  

Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study

  1. TitleRisk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study
    Author infoAntonelli L., Mego M. ... [et al.]
    Co-authors Mego Michal
    Corporation Redakcia Onkológia
    NoteEur J Cancer. 2023 Mar;182:144-154
    Sign.C 3069
    Source Onkológia. - ISSN 1336-8176. - Bratislava : SOLEN , 2023 . - Roč. 18, č. 2 (2023), s. 160-161
    MeSH Subject nádory z germinatívnych a embryonálnych buniek
    teratóm
    nádor reziduálny
    miera prežívania
    Form, Genre abstrakt v angličtine
    Subj. Headings nádory zo zárodočných buniek neseminomatózne metastatické * vyhodnotenie súboru pacientov retrospektívne
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.